San Daniele del Friuli, Udine, Italy – 2nd August 2019 LimaCorporate has announced the completion of a distribution agreement with G21 for the SpaceFlex Cement Spacer portfolio for the European Economic Area (EEA), Switzerland, Australia and New Zealand markets. G21’s mission is to develop innovative, patented, high-quality and customer-driven cement spacer molds for shoulder, hip …
All News
August 02, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that …
AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide sales were $194.5 million, an increase of 12.2% as reportedSecond quarter net income was $38.2 millionDiluted earnings per share (EPS) was $0.38 and non-GAAP diluted EPS was …
CARLSBAD, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of the first surgery for its Shoreline RT Cervical Interbody Implant System. Shoreline RT represents the first in a …
DEERFIELD, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2019. Second Quarter 2019 Highlights: Revenue of $82.3 million, up approximately 16% compared to the second quarter of 2018Net income of $0.7 millionAdjusted EBITDA of $9.9 million, or …
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has entered into a securities purchase agreement with Arena Investors LP (“Arena”). The agreement provides for the issuance and sale to Arena of 5,500,000 shares of Series …
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1